Jorey Chernett reports 5.4% Exagen (XGN) stake in Schedule 13G

Rhea-AI Filing Summary

Jorey Chernett has filed a Schedule 13G reporting a significant ownership stake in Exagen Inc. The filing states beneficial ownership of 1,231,438 shares of Exagen common stock, representing about 5.4% of the class, with sole voting and dispositive power over all reported shares.

The filer certifies the securities were not acquired and are not held for the purpose of changing or influencing control of Exagen, and are not held in connection with any transaction having that purpose or effect, other than activities solely in connection with a nomination under the specified SEC rule.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

EXAGEN INC.

(Name of Issuer)

Common

(Title of Class of Securities)

30068X103

(CUSIP Number)

01/30/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 30068X103

1

Names of Reporting Persons

Chernett Jorey

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 1,231,438.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 1,231,438.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

1,231,438.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.4 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: EXAGEN INC.
(b)	Address of issuer's principal executive offices: 1261 Liberty Way, Vista, CALIFORNIA, 92081.
Item 2.
(a)	Name of person filing: Jorey Chernett
(b)	Address or principal business office or, if none, residence: 6222 Indianwood Trail, Bloomfield Hills, MI 48301
(c)	Citizenship: US
(d)	Title of class of securities: Common
(e)	CUSIP No.: 30068X103
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 1,231,438
(b)	Percent of class: 5.43%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 1,231,438
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 1,231,438
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Chernett Jorey

Signature:	/s/Jorey Chernett
Name/Title:	Individual
Date:	02/04/2026

FAQ

What ownership stake in Exagen Inc. (XGN) does Jorey Chernett report?

The filing reports that Jorey Chernett beneficially owns 1,231,438 shares of Exagen Inc. common stock, representing approximately 5.4% of the class. The shares are held with sole voting and sole dispositive power, with no shared voting or dispositive authority disclosed.

What type of securities does this Schedule 13G for Exagen Inc. (XGN) cover?

The Schedule 13G covers Exagen Inc. common stock, identified by CUSIP 30068X103. It details beneficial ownership, including the number of shares, percentage of the class, and the filer’s sole voting and dispositive powers over those common shares as of the reported event date.

How much of Exagen Inc. (XGN) does 1,231,438 shares represent in this filing?

According to the Schedule 13G, the 1,231,438 Exagen Inc. common shares beneficially owned by Jorey Chernett represent about 5.43% of the outstanding class. This percentage is calculated as of the date of the event that triggered the filing requirement stated in the document.

Does Jorey Chernett share voting or dispositive power over Exagen Inc. (XGN) shares?

No shared authority is disclosed. The filing states that Jorey Chernett has sole power to vote and sole power to dispose of 1,231,438 Exagen Inc. common shares, with shared voting power and shared dispositive power each reported as zero in the ownership table.

What intent regarding control of Exagen Inc. (XGN) is certified in this Schedule 13G?

The filer certifies the securities were not acquired and are not held to change or influence control of Exagen Inc. The certification also states they are not held in connection with any transaction having that purpose, other than activities solely related to a nomination under the cited SEC rule.

When did the ownership event occur that triggered this Exagen Inc. (XGN) Schedule 13G?

The Schedule 13G lists January 30, 2026 as the date of the event requiring the filing. That date is used as the reference point for the reported beneficial ownership, share count, and percentage of Exagen Inc. common stock disclosed in the document.